Abstract:Hypoxia-ischemia is the most common cause of neonatal encephalopathy (NE). In most cases, an intrapartum event is presumed to lead to perinatal hypoxia ischemia, but the exact pathogenesis, and therefore timing, are often not known. 1 In well-resourced settings, therapeutic hypothermia (TH) reduces death and major neurodevelopmental disability in infants with NE. 2 However, there is heterogeneity in outcomes, and major neurodevelopmental disability is still seen in about one third of survivors who are treated with therapeutic hypothermia. 3 The heterogeneity in response of NE to TH means alternative treatments are desperately sought. As such, many biomarkers have been studied as surrogate measures of long-term outcome, in order to expedite assessment of potential treatments. Moreover, an important goal is to personalize treatment for NE such that individuals who might benefit from a different approach to TH, might be detected early. It is also important to study biomarkers that can discriminate between which babies benefit from TH versus those who may be at higher risk of an adverse outcome. 4 In the study by O'Gorman Tuura et al., the authors have explored the link between perfusion and neurodevelopmental outcomes using arterial spine labeling (ASL) as a neuroimaging marker for outcome prediction. 5 ASL is a noninvasive magnetic resonance imaging (MRI) technique in which protons in blood and water are magnetically labeled and the signal generated by the endogenous labels are detected by subtracting MRI signals during alternating labeled and unlabeled acquisitions. The images demonstrate signal intensity proportional to the amount of perfusion in each voxel and a quantitative measurement of cerebral blood flow (CBF) can be calculated. 6 Previous authors have described patterns of CBF using ASL in NE. Wintermark et al. demonstrated initial hypoperfusion on day 1 followed by hyperperfusion at days 2–3. 7 A study by Tang et al. reported lower CBF values in neonates with NE at 0–24 h and 3–7 days with higher values in the 1–3 day-old group. 8 The mean age at MRI in O'Gorman Tuura's paper was 5 days (range 3–9 days), which means that any hyperperfusion identified may not represent the 'peak' perfusion phase, but rather the tail end of the more severe cases. The problem with that theory is that the cohort studied included infants with mild to moderate NE and the authors found a relationship between altered perfusion and outcome even in those children with mild to moderate impairment following NE.

Apparent diffusion coefficient values can predict neuromotor outcome in term neonates with hypoxic-ischaemic encephalopathy

Diagnostic value of amplitude-integrated electroencephalography in predicting outcome of newborn patients in neonatal intensive care unit

Amide Proton Transfer and Apparent Diffusion Coefficient Analysis Reveal Susceptibility of Brain Regions to Neonatal Hypoxic-Ischemic Encephalopathy

The Role of ADC Values in Evaluating Follow-Up Value of Neonatal Hypoxic-Ischemic Encephalopathy: Initial Experience

Predictive Value of MRI in Hypoxic-Ischemic Encephalopathy Treated with Therapeutic Hypothermia

Predictors Of Neurodevelopmental Outcomes At 12 Months In Term Newborns With Hypoxic Ischemic Encephalopathy

Applied Value of Diffusion Tensor Imaging in Early Evaluation of Prognosis of Hypoxic-Ischemic Encephalopathy in New Infants

Investigate the value of diffusion weighted MRI and proton MRS in early diagnosing hypoxic-ischemic encephalopathy in full-term infants

Diffusion Tensor Imaging Assesses White Matter Injury in Neonates with Hypoxic-Ischemic Encephalopathy.

MR imaging and outcome in neonatal HIBD models are correlated with sex: the value of diffusion tensor MR imaging and diffusion kurtosis MR imaging

Study on the Application of Diffusion Weighted Imaging in Evaluation of Hypoxic-ischemic Encepha-lopathy in Neonates

Diagnostic Performance of Arterial Spin-Labeled Perfusion Imaging and Diffusion-Weighted Imaging in Full-Term Neonatal Hypoxic-Ischemic Encephalopathy

[Meta-Analysis of Prognostic Tests in Neonates over 35-Week Gestational Age with Hypoxic-Ischemic Encephalopathy].

Cerebral blood flow in neonatal encephalopathy: biomarker or potential target?

Evaluation of Brain Microstructure Changes in Surviving Fetus of Monochorionic Twin Pregnancies With Demise of One Fetus Using Apparent Diffusion Coefficient

Regional changes in brain apparent diffusion coefficient in fetuses with complex congenital heart disease and normal pregnancy assessed using diffusion-weighted imaging

Individualized Neuroprognostication in Neonates With Hypoxic-Ischemic Encephalopathy Treated With Hypothermia

Does abnormal Doppler on cranial ultrasound predict disability in infants with hypoxic‐ischaemic encephalopathy? A systematic review

Usefulness of apparent diffusion coefficient values for assessment of MRI abnormality at term equivalent age in low-birth-weight infants weighing less than 1500 g

Clinical Significance of Electroencephalography Power Spectrum Density and Functional Connection Analysis in Neonates with Hypoxic-Ischemic Encephalopathy

Early Morbidities of Hypoxia-Ischemic Encephalopathy in Term Neonates With a Resistive Index as a Prognostic Indicator